Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

SQSQZB
7 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in SQZ Biotechnologies Co

No. Stifel exited its SQZB (SQZ Biotechnologies) position in Q3 2023. Its Q2 2023 13F listed 851,520 shares worth $229,911. Stifel first reported SQZB in Q1 2022 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$842,000

Total Shares Change

-174,969

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$0.08
0
2023-Q2
Decreased
851,520
-2.6%
$229,9110.0%$0.30
0
2023-Q1
Decreased
874,326
-15.6%
$489,6220.0%$0.57
0
2022-Q4
Increased
1M
+111.3%
$766,3130.0%$0.74
40
2022-Q3
Increased
490,206
+5.4%
$1.1M0.0%$2.21
27
2022-Q2
Increased
465,032
+165.8%
$1.5M0.0%$3.16
41
2022-Q1
New
174,969
-
$842,0000.0%$4.75
34

Other major holders of SQZB: Temasek Holdings (Private) Ltd, MAVERICK CAPITAL LTD

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used